Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19
Dhanusha A. Nalawansha, Kusal T. G. Samarasinghe
Abstract
delivery of CRISPR components and propose novel approaches to achieve selective delivery exclusively into SARS-CoV-2-infected cells with high efficiency by hijacking the surface proteins of SARS-CoV-2.
Topics & Concepts
CRISPRCoronavirus disease 2019 (COVID-19)CoronavirusPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakOutbreakDiseaseBiologyMedicineInfectious disease (medical specialty)GenePathologyGeneticsCRISPR and Genetic EngineeringSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology Research